收藏切换
Clinical research progress on semaglutide in the treatment of type 2 diabetes mellitus
收藏切换
Na NI1, Shujun YANG2, Ziwen DING1, Jingyan ZHANG3, Song ZHANG3, Junlong WANG3, *, Bing ZHOU2, *
World Clinical Drug | 2022, 43(6) : 787 - 792
Less
收藏切换
World Clinical Drug | 2022, 43(6): 787-792
• Review •
Clinical research progress on semaglutide in the treatment of type 2 diabetes mellitus
Full
Na NI1, Shujun YANG2, Ziwen DING1, Jingyan ZHANG3, Song ZHANG3, Junlong WANG3, *, Bing ZHOU2, *
Affiliations
  • 1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
  • 2.China National Pharmaceutical Industry Information Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
  • 3.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China
Published: 2022-06-10 doi: 10.13683/j.wph.2022.06.024
Outline
收藏切换

National Medical Products Administration approved the import of semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA) in April 2021. As a long-acting GLP-1RA, this product has demonstrated its efficacy and safety through pharmacokinetic studies, SUSTAIN studies and SURE studies before listing. Levels of blood glucose and glycosylated hemoglobin can be reduced with lower incidence of hypoglycemia, lower body weight and lower risk of cardiovascular disease. This article summarized the main clinical research data of semaglutide and relative mechanisms in the treatment of type 2 diabetes mellitus, providing reference for clinical use of semaglutide.

semaglutide  /  type 2 diabetes mellitus  /  clinical research  /  glucagon-like peptide-1 receptor agonist
倪娜, 杨树俊, 丁子文, 张婧妍, 张松, 王俊龙, 周斌. 司美格鲁肽治疗2型糖尿病的临床研究进展. 世界临床药物, 2022 , 43 (6) : 787 -792 . DOI: 10.13683/j.wph.2022.06.024
Na NI, Shujun YANG, Ziwen DING, Jingyan ZHANG, Song ZHANG, Junlong WANG, Bing ZHOU. Clinical research progress on semaglutide in the treatment of type 2 diabetes mellitus[J]. World Clinical Drug, 2022 , 43 (6) : 787 -792 . DOI: 10.13683/j.wph.2022.06.024
Year 2022 volume 43 Issue 6
10
1
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.06.024
  • Receive Date:2021-07-28
  • Online Date:2026-11-19
  • Published:2022-06-10
Article Data
Affiliations
History
  • Received:2021-07-28
  • Revised:2022-03-16
Affiliations
    1.Clinical Research Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
    2.China National Pharmaceutical Industry Information Center, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
    3.Shanghai Clinical Research Organization for Medicines, Shanghai 200437, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.06.024
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT